SEAT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Vivid Seats Inc (SEAT) does not present a compelling buy opportunity for a beginner, long-term investor at this time. While there are some positive signs such as hedge fund buying and potential upside from operational improvements, the company's recent financial performance, mixed analyst ratings, and lack of strong proprietary trading signals suggest caution. The investor should wait for clearer signs of stabilization and growth before considering an investment.
The stock is showing some positive momentum with a MACD histogram of 0.156 (above 0 and expanding positively) and a pre-market price increase of 2.97%. However, the RSI of 72.837 is in the neutral zone, and moving averages are converging, indicating no strong trend. Key resistance levels are at 7.83 and 8.356, while support levels are at 6.126 and 5.6.
Hedge funds have significantly increased their buying activity by 112.86% over the last quarter. Craig-Hallum upgraded the stock to Buy with a $15 price target, citing high operating and financial leverage with potential upside. Signs of stabilization in troubled parts of the business were noted by RBC Capital.
The company's Q4 2025 financials showed a 36.53% YoY revenue decline and ongoing competitive pressures. Analysts have lowered price targets significantly, with Morgan Stanley and BofA expressing concerns about continued GOV declines and competitive uncertainty. Insider trading activity is neutral, and there is no recent congress trading data.
In Q4 2025, revenue dropped by 36.53% YoY to $126.8M. Net income improved significantly but remains negative at -$275.16M. EPS increased to -29.43, but gross margin fell by 14.68% YoY to 57.54%. The financials indicate a struggling business with some operational improvements but no clear path to profitability.
Analyst sentiment is mixed. Craig-Hallum upgraded the stock to Buy with a $15 target, citing potential upside, while firms like Morgan Stanley and BofA lowered price targets to $7 and $5.65, respectively, citing competitive pressures and declining GOV. The average sentiment leans towards caution, with some optimism for long-term recovery.
